Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Neurology

Long-Term Care, Monitoring, & Genetics

At a Glance

Long-term care for ADCA-DN is best coordinated across neurology, sleep, hearing, rehabilitation, and mental health services. Monitoring safety and cognition, genetic counseling about the 50% inheritance risk, and early advance care planning help protect independence and personal choices.

Living with Autosomal Dominant Cerebellar Ataxia-Deafness-Narcolepsy Syndrome (ADCA-DN) is a long-term journey that requires more than just managing individual symptoms. Because the condition is progressive and affects multiple systems—balance, hearing, sleep, and cognition—the best care comes from a multidisciplinary team that communicates regularly [1][2].

As you navigate this diagnosis, the focus shifts toward proactive monitoring, ensuring family health, and planning for a future that honors your values and independence.

Building Your Multidisciplinary Care Team

No single doctor can manage ADCA-DN alone. Follow-up frequency depends entirely on your specific symptoms, treatment changes, fall risks, cognition, and access to local specialty care [3][4]. Your core team should ideally include:

  • Neurology & Medical Genetics: To manage ataxia and coordinate DNMT1-specific care [1].
  • Sleep Medicine: To monitor narcolepsy and adjust wake-promoting medications [5].
  • Audiology & ENT: To track hearing loss and evaluate for hearing aids or cochlear implants [6].
  • PT/OT & Speech Therapy: To work on balance, fall prevention, and swallowing safety [7][8].
  • Psychiatry & Neuropsychology: To support mental health and monitor for changes in cognitive function [9].

Safety in Daily Life

As ADCA-DN progresses, safety monitoring becomes a vital part of your routine. This is not about taking away your independence, but about finding the right tools to keep you moving safely [10].

  • Fall Prevention: Your team will use clinical tools, like the SARA (Scale for the Assessment and Rating of Ataxia), to track your balance [7]. If you experience frequent “near-misses” or stumbles, it may be time to consider home modifications (like grab bars) or mobility aids [10][11]. Note that tests like the SARA are clinician tools, not complete measures of how well you are functioning at home.
  • Driving and Machinery: The combination of ataxia (coordination) and narcolepsy (unpredictable sleepiness) can make driving or operating heavy machinery dangerous [12]. Your doctor may recommend an optional evaluation component like a Maintenance of Wakefulness Test (MWT) as part of an occupational-driving assessment. However, an MWT is not a stand-alone legal clearance; you must abide by your local licensing rules regarding neurodegenerative and sleep disorders [13].

Genetic Counseling for Your Family

Because ADCA-DN is an autosomal dominant condition, each biological child has a 50% chance of inheriting the pathogenic variant [14]. This reality makes genetic counseling an essential resource for your relatives [15].

  • Predictive Testing: For adult relatives who do not have symptoms, testing is a deeply personal decision. Best practices recommend a structured process that includes counseling to discuss the emotional, legal, and insurance implications before a test is even ordered [16][17].
  • Testing Minors: Testing an asymptomatic minor is generally deferred because there is typically no immediate childhood medical benefit to diagnosing an adult-onset condition [16][18]. However, counseling can begin earlier, and any young person who is symptomatic requires immediate clinical evaluation.
  • Support: A genetic counselor can provide a “family letter” to help you explain the condition to relatives and guide them toward their own specialized care [19].

Advance Care Planning: Starting Early

ADCA-DN can sometimes lead to “executive dysfunction”—difficulty with complex planning and decision-making—or even dementia as it progresses [6][20]. This makes advance care planning (ACP) particularly important.

  • Preserving Your Voice: ACP is not a prediction that dementia is imminent; it is most effective when it begins early, while you are fully able to communicate your values and preferences [21][22].
  • Choosing a Surrogate: One of the most important steps is legally designating a healthcare proxy or surrogate decision-maker using locally valid forms. This is someone who understands your wishes and can speak for you if you are ever unable to do so [23][24].
  • Documenting Values: Beyond just “living wills,” discuss what “quality of life” means to you. For example, if you were unable to communicate, what care priorities would you want your family to focus on? [25][26].

By organizing your care and having these difficult conversations early, you ensure that your medical journey remains centered on your choices and your well-being [21].

Common questions in this guide

Which doctors should coordinate my long-term ADCA-DN care?
ADCA-DN care usually involves neurology or medical genetics, sleep medicine, audiology or ENT, physical and occupational therapy, speech therapy, and mental health professionals. One clinician should help coordinate results and follow-up, with visit frequency tailored to symptoms, treatment changes, fall risk, cognition, and local access.
How are balance and fall risk monitored in ADCA-DN?
Clinicians may use the Scale for the Assessment and Rating of Ataxia, called SARA, to track coordination and balance over time. The score does not fully show how safely you function at home, so frequent stumbles or near-falls should prompt discussion of home changes, grab bars, or mobility aids.
Can I drive if I have ADCA-DN and narcolepsy?
Ataxia and unpredictable sleepiness can make driving or operating heavy machinery unsafe. A formal driving or occupational assessment may include a Maintenance of Wakefulness Test, but that test alone is not legal clearance; follow local licensing rules and your clinician’s advice.
What is the chance my child will inherit ADCA-DN?
Because ADCA-DN is autosomal dominant, each biological child of a person with the pathogenic variant has a 50% chance of inheriting it. A genetic counselor can explain what this risk means for your family and discuss testing or family-planning options.
Should an asymptomatic child or adult relative have genetic testing?
Adult predictive testing is a personal decision and ideally begins with genetic counseling about emotional, legal, and insurance considerations. Testing an asymptomatic minor is generally deferred when the condition is adult-onset and there is no immediate childhood medical benefit; a symptomatic young person should be evaluated promptly.
Why should I make an advance care plan early?
ADCA-DN can cause executive dysfunction or dementia over time, so planning early helps you document your values and appoint a healthcare proxy while you can clearly communicate. Starting advance care planning does not mean dementia is imminent; it helps preserve your voice if decision-making later becomes difficult.
What support can help me stay safe and independent with ADCA-DN?
Home modifications such as grab bars, mobility aids, and physical or occupational therapy can reduce fall risk, while speech therapy may address swallowing safety. Audiology and ENT can assess hearing aids or cochlear implants, and sleep specialists can adjust wake-promoting treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which of my specialists is the primary 'care coordinator' responsible for syncing my neurology, sleep, and audiology results?
  2. 2.How often should we repeat my 'SARA' (ataxia) and balance scores to determine when I need to adjust my home safety or mobility aids?
  3. 3.Can we schedule a formal driving safety evaluation given the combination of my narcolepsy and ataxia?
  4. 4.Who on the team can help me document my medical values and preferences in a way that will be accessible to all my doctors?
  5. 5.Do you have a standard 'family letter' I can share with my relatives to help them start the conversation with a genetic counselor?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (26)
  1. 1

    Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.

    Bremova-Ertl T, Hofmann J, Stucki J, et al.

    Cells 2023; (12(18)) doi:10.3390/cells12182314.

    PMID: 37759536
  2. 2

    Epidemiology of Cerebellar Diseases and Therapeutic Approaches.

    Salman MS

    Cerebellum (London, England) 2018; (17(1)):4-11 doi:10.1007/s12311-017-0885-2.

    PMID: 28940047
  3. 3

    Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients.

    Hadjivassiliou M, Martindale J, Shanmugarajah P, et al.

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(4)):301-309 doi:10.1136/jnnp-2016-314863.

    PMID: 27965395
  4. 4

    Long-Term Effects of Annual Intensive Rehabilitation in Patients with Hereditary Pure Cerebellar Ataxia: A 7-year Follow-up Study.

    Bando K, Kondo Y, Ariake Y, et al.

    Cerebellum (London, England) 2025; (24(5)):150 doi:10.1007/s12311-025-01899-8.

    PMID: 40906249
  5. 5

    Cataplexy and ataxia: red flags for the diagnosis of DNA methyltransferase 1 mutation.

    Postiglione E, Antelmi E, Pizza F, et al.

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2020; (16(1)):143-147 doi:10.5664/jcsm.8140.

    PMID: 31957642
  6. 6

    Autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN) associated with progressive cognitive and behavioral deterioration.

    Walker LA, Bourque P, Smith AM, Warman Chardon J

    Neuropsychology 2017; (31(3)):292-303 doi:10.1037/neu0000322.

    PMID: 27869457
  7. 7

    Rehabilitation for ataxia study: protocol for a randomised controlled trial of an outpatient and supported home-based physiotherapy programme for people with hereditary cerebellar ataxia.

    Milne SC, Corben LA, Roberts M, et al.

    BMJ open 2020; (10(12)):e040230 doi:10.1136/bmjopen-2020-040230.

    PMID: 33334834
  8. 8

    Patients' Perspective in Hereditary Ataxia.

    Gorcenco S, Karremo C, Puschmann A

    Cerebellum (London, England) 2024; (23(1)):82-91 doi:10.1007/s12311-022-01505-1.

    PMID: 36525215
  9. 9

    Diagnosis and Management of Dementia: Review.

    Arvanitakis Z, Shah RC, Bennett DA

    JAMA 2019; (322(16)):1589-1599 doi:10.1001/jama.2019.4782.

    PMID: 31638686
  10. 10

    Goal-Directed Rehabilitation Versus Standard Care for Individuals with Hereditary Cerebellar Ataxia: A Multicenter, Single-Blind, Randomized Controlled Superiority Trial.

    Milne SC, Roberts M, Williams S, et al.

    Annals of neurology 2025; (97(3)):409-424 doi:10.1002/ana.27130.

    PMID: 39520242
  11. 11

    Three-Week Video- and Home-Based Training Program for People with Ataxia: A Pilot Randomized Controlled Trial.

    Rentz C, Reinhardt A, Jung N, et al.

    Movement disorders clinical practice 2025; (12(12)):2154-2167 doi:10.1002/mdc3.70225.

    PMID: 40654311
  12. 12

    Driving Safety and Fitness to Drive in Sleep Disorders.

    Tippin J, Dyken ME

    Continuum (Minneapolis, Minn.) 2017; (23(4, Sleep Neurology)):1156-1161 doi:10.1212/CON.0000000000000490.

    PMID: 28777182
  13. 13

    A Case of A Sleepy Taxi Driver Presenting with Narcolepsy.

    Miskoff JA, Chaudhri M

    Cureus 2019; (11(6)):e4901 doi:10.7759/cureus.4901.

    PMID: 31423380
  14. 14

    Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy.

    Kernohan KD, Cigana Schenkel L, Huang L, et al.

    Clinical epigenetics 2016; (8()):91 doi:10.1186/s13148-016-0254-x.

    PMID: 27602171
  15. 15

    Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.

    Baets J, Duan X, Wu Y, et al.

    Brain : a journal of neurology 2015; (138(Pt 4)):845-61 doi:10.1093/brain/awv010.

    PMID: 25678562
  16. 16

    Human Genetics Society of Australasia Position Statement: Predictive and Presymptomatic Genetic Testing in Adults and Children.

    Vears DF, McLean A, La Spina C, et al.

    Twin research and human genetics : the official journal of the International Society for Twin Studies 2024; (27(2)):120-127 doi:10.1017/thg.2024.9.

    PMID: 38509872
  17. 17

    Defining the Critical Components of Informed Consent for Genetic Testing.

    Ormond KE, Borensztein MJ, Hallquist MLG, et al.

    Journal of personalized medicine 2021; (11(12)) doi:10.3390/jpm11121304.

    PMID: 34945775
  18. 18

    Human Genetics Society of Australasia Position Statement: Predictive and Presymptomatic Genetic Testing in Adults and Children.

    Vears DF, Ayres S, Boyle J, et al.

    Twin research and human genetics : the official journal of the International Society for Twin Studies 2020; (23(3)):184-189 doi:10.1017/thg.2020.51.

    PMID: 32635964
  19. 19

    How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes.

    van den Heuvel LM, Smets EMA, van Tintelen JP, Christiaans I

    Journal of genetic counseling 2019; (28(5)):1042-1058 doi:10.1002/jgc4.1143.

    PMID: 31216099
  20. 20

    Cerebellar Ataxia-deafness-narcolepsy (ADCA) syndrome. Description of a variable family phenotype.

    Abenza-Abildúa MJ, Palmí-Cortés I, Ojeda-Ruiz de Luna J, et al.

    Acta neurologica Belgica 2025; (125(5)):1395-1399 doi:10.1007/s13760-025-02776-1.

    PMID: 40285998
  21. 21

    Optimizing Advance Care Planning in Dementia: Recommendations From a 33-Country Delphi Study.

    van der Steen JT, Van den Block L, Nakanishi M, et al.

    Journal of pain and symptom management 2025; (69(6)):e755-e772 doi:10.1016/j.jpainsymman.2025.02.471.

    PMID: 40032035
  22. 22

    Advance care planning in progressive neurological diseases: lessons from ALS.

    Seeber AA, Pols AJ, Hijdra A, et al.

    BMC palliative care 2019; (18(1)):50 doi:10.1186/s12904-019-0433-6.

    PMID: 31196046
  23. 23

    Advance care planning in neurologic illness.

    Macchi ZA, Lum HD

    Handbook of clinical neurology 2022; (190()):129-148 doi:10.1016/B978-0-323-85029-2.00004-X.

    PMID: 36055711
  24. 24

    Advance Care Planning in Cognitively Impaired Older Adults.

    deLima Thomas J, Sanchez-Reilly S, Bernacki R, et al.

    Journal of the American Geriatrics Society 2018; (66(8)):1469-1474 doi:10.1111/jgs.15471.

    PMID: 30277566
  25. 25

    Advance Care Planning for People with Dementia: The Role of General Practitioners.

    Bally KW, Krones T, Jox RJ

    Gerontology 2020; (66(1)):40-46 doi:10.1159/000500809.

    PMID: 31212289
  26. 26

    Future policy and research for advance care planning in dementia: consensus recommendations from an international Delphi panel of the European Association for Palliative Care.

    Nakanishi M, Martins Pereira S, Van den Block L, et al.

    The lancet. Healthy longevity 2024; (5(5)):e370-e378 doi:10.1016/S2666-7568(24)00043-6.

    PMID: 38608695

This page explains long-term care, genetic counseling, and advance planning for ADCA-DN for educational purposes only; it is not medical advice. Discuss monitoring, testing, driving, and legal documents with your own clinicians and genetic counselor.

Get notified when new evidence is published on Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.